Clinical Trial: A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669727) titled 'A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.' on May 29.

Brief Summary: The purpose of this study is to assess the safety and effectiveness of treating a tumor using a different planning method called MCD for the FDA-Approved device, TheraSphere.

TheraSphere Microspheres are microscopic radioactive glass spheres that deliver radiation therapy in the liver tissue where they are placed. This study investigates a procedure called multicompartment dosimetry (MCD). When using a multicompartment dosimetry approach, the doctor will look at images of the liver to see where there is tu...